Teplizumab, a drug already approved in the US, is being tested in the UK to slow the progression of type 1 diabetes by training the immune system to protect pancreatic cells. Hannah Robinson, the first British adult to receive the treatment, hopes it will delay the need for insulin. Experts believe the treatment represents a major change in diabetes management, with the potential to alter the immune process and help high-risk people avoid insulin therapy.
Sources
Un medicament "revoluţionar" ar putea încetini evoluţia diabetului de tip 1. Poate întârzia nevoia de insulină cu 3 ani
Devon mother treated with game-changing diabetes drug
Mother of two becomes the first UK patient to receive ‘groundbreaking’ new diabetes drug
Un medicament „revoluționar”, o nouă speranță pentru diabetul de tip 1. Ce așteptări au medicii
Latest News
23:48
Prince Harry says he would enlist in the British Army again and warns that Europe must be prepared in the face of Russia
23:16
A Romanian man without a license stole a car and fled from police in Spain / The chase ended in a head-on collision
22:50
Hakeem Jeffries will lead the U.S. House of Representatives, becoming the first Black politician to hold the position
22:21
Eugen Tomac calls for reforming public administration and says that the option of eight regions can be analyzed
22:02
Traian Băsescu says Marian Neacșu will be the “executive prime minister” of the Luca Niculescu Government
See more news